Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 2, 2015

View Archived Issues

PCORI approves USD 83 million to fund patient-centered clinical effectiveness research studies

LDC and Infinity Pharmaceuticals to cooperate in oncology drug discovery and development

Novavax receives Gates Foundation grant to develop RSV vaccine; reports phase I and II results

Amydis Diagnostics awarded NIA-NIH grant for technology to detect Alzheimer's disease

Heraeus Medical and OrthoCyte agree to develop stem cell based bone graft product

Cloud Pharmaceuticals and THERAMetrics collaborate in orphan CNS diseases

Astellas and Chromocell sign license and collaboration agreement in neuropathic pain

Downregulation of lysyl oxidase prevents vascular lesions in diabetic retinopathy

Aspen Park Pharmaceuticals acquires drug to treat castration-resistant prostate cancer

Epicardial Fstl1 promotes cardiomyocyte regeneration after myocardial infarction

Naproxcinod superior to naproxen in mouse model of DMD

GSK exercises option to license inhaled therapeutics under Liquidia collaboration

The Leukemia & Lymphoma Society commits new funding to support cancer research

European Union funds 4SC research project EMTherapy

Phase III METEOR trial data: cabozantinib in advanced kidney cancer

Effect of TRL-1068 on biofilms

Bristol-Myers Squibb receives FDA approval for Opdivo + Yervoy in metastatic melanoma

XBiotech's 514G3 receives FDA fast track designation for serious infections

Seno Medical Instruments completes final phase of PIONEER study

Breast Cancer Awareness Month: Testing a new approach

Xoma licenses first-in-class anti-TGF-beta antibody program to Novartis

Amicus Therapeutics completes acquisition of Scioderm

Roche and Siena Biotech report BACE1 inhibitors

reMYND presents compounds for protein-misfolding disorders

Boehringer Ingelheim presents SYK inhibitors

Bayer presents new soluble guanylate cyclase activators

Otologic licenses sensory hair cell regeneration technology from Hough Ear Institute

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Viva in vivo! At EHA, in vivo CAR T data continues to impress
BioWorld
Treatment with first-generation CAR T cells regularly sent patients to the intensive care unit. Now, investigators are envisioning a future where CAR T treatment...